Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01339988
What this trial is testing

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Who this might be right for
Acute LeukemiasChronic LeukemiasMyelodysplastic Syndrome+1 more
Tel-Aviv Sourasky Medical Center 10
Large-scale testing (Phase 3)UnknownNCT00002869
What this trial is testing

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Medical Research Council 800
Early research (Phase 1)Ended earlyNCT03110354
What this trial is testing

DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute
Daiichi Sankyo 28
Not applicableStudy completedNCT04169022
What this trial is testing

AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Besancon 86
Testing effectiveness (Phase 2)Study completedNCT00144131
What this trial is testing

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

Who this might be right for
AnemiaCancer
Amgen 750
Not applicableUnknownNCT02759822
What this trial is testing

Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Leonardo Javier Arcuri 30
Early research (Phase 1)Not Yet RecruitingNCT07583303
What this trial is testing

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 19
Early research (Phase 1)Not Yet RecruitingNCT06463327
What this trial is testing

ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
TC Biopharm 69
Very early researchUnknownNCT06541405
What this trial is testing

Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Base Therapeutics (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT00462605
What this trial is testing

MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+25 more
National Cancer Institute (NCI) 24
Not applicableWithdrawnNCT01176422
What this trial is testing

Telomere and Telomerase

Who this might be right for
Acute Myeloid Leukemia
University of Kansas Medical Center
Not applicableStudy completedNCT01362179
What this trial is testing

National Marrow Donor Program Long-Term Donor Follow-Up

Who this might be right for
Hematologic Neoplasms
Center for International Blood and Marrow Transplant Research 21,974
Testing effectiveness (Phase 2)Study completedNCT01830361
What this trial is testing

Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 18
Testing effectiveness (Phase 2)Looking for participantsNCT07392242
What this trial is testing

The Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Ended earlyNCT04679194
What this trial is testing

Study of Mana 312 (Multi Tumor-Associated Antigen T Cells) in Adults With AML/MDS After HSCT

Who this might be right for
AML/MDS
Mana Therapeutics 11
Not applicableEnded earlyNCT03549351
What this trial is testing

Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital Heidelberg 51
Not applicableActive Not RecruitingNCT06092879
What this trial is testing

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 201
Large-scale testing (Phase 3)Study completedNCT00514488
What this trial is testing

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)

Who this might be right for
Chronic Myeloid Leukemia
University of Bologna
Next Page